In recent years, KPNA2 has emerged as a potential biomarker in multiple forms of cancer, including breast carcinoma [6], lung cancer [7], melanoma [8], hepatocellular carcinima [9], and gastric carcinoma [10]. Here, KPNA2 is linked to lung cancer.